Frontal skull reshaping for moderate skull fusion
Part of Bones, joints & muscles, Genetic & congenital clinical trials.
This trial tests a surgical technique to reshape the front of the skull in infants with moderate metopic craniosynostosis (early fusion of the skull's front plates). The goal is to improve head shape without moving the eye sockets forward.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has been diagnosed with isolated metopic craniosynostosis (not part of a syndrome).
- The condition is moderate in severity, typically measured by a frontal angle between 90° and 95°.
- Your child does not have mild or severe forms of this condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches for children with trigonocephaly (a condition where the skull has a triangular shape): surgery or careful monitoring without surgery. The goal is to understand which approach leads to better clinical results, emotional well-being, and lower costs.
This study looks at eye features in people with craniosynostosis (a condition where skull bones fuse too early). It may help doctors better understand eye problems that can occur with this condition.
This study tests a new 3D-printed guide to help surgeons perform skull reshaping surgery for young children with craniosynostosis (early skull bone fusion). It aims to improve safety and precision during surgery.
This study looks at the skull bones and stitches (sutures) removed during surgery for craniosynostosis to learn more about their structure. It may help doctors understand better how to treat this condition.
This trial tests whether using a 3D virtual model to plan surgery and pre-bend plates helps surgeons repair fractures around the nose, eye socket, and forehead more accurately. This may lead to better facial alignment and recovery.
This study tests a new treatment called ASO (antisense oligonucleotide) therapy on tissue samples from babies with syndromic craniosynostosis—a condition where skull bones fuse too early due to specific genetic changes. Researchers hope this approach could eventually help prevent or reduce the severity of this condition.
Hear when a new Craniosynostosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.